| X23-10-ZQ325 |
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
|
|
| X23-10-ZQ351 |
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
|
|
| X23-10-ZQ352 |
JAK inhibitor Abrocitinib, Purity ≥98%
|
|
| X23-10-ZQ355 |
JAK inhibitor AZ-3, Purity ≥98%
|
|
| X23-10-ZQ356 |
JAK inhibitor AZ-960, Purity ≥98%
|
|
| X23-10-ZQ357 |
JAK inhibitor AZD1480, Purity ≥98%
|
|
| X23-10-ZQ358 |
JAK inhibitor Baricitinib, Purity ≥98%
|
|
| X23-10-ZQ359 |
JAK inhibitor Baricitinib phosphate, Purity ≥98%
|
|
| X23-10-ZQ360 |
JAK inhibitor BD750, Purity ≥98%
|
|
| X23-10-ZQ361 |
JAK inhibitor BMS-066, Purity ≥98%
|
|
| X23-10-ZQ362 |
JAK inhibitor BMS-911543, Purity ≥98%
|
|
| X23-10-ZQ363 |
JAK inhibitor BMS-986165, Purity ≥98%
|
|
| X23-10-ZQ364 |
JAK inhibitor CEP33779, Purity ≥98%
|
|
| X23-10-ZQ365 |
JAK inhibitor Cercosporamide, Purity ≥98%
|
|
| X23-10-ZQ366 |
JAK inhibitor Cerdulatinib, Purity ≥98%
|
|
| X23-10-ZQ367 |
JAK inhibitor CHZ868, Purity ≥98%
|
|
| X23-10-ZQ368 |
JAK inhibitor Tofacitinib citrate, Purity ≥98%
|
|
| X23-10-ZQ369 |
JAK inhibitor Cucurbitacin I, Purity ≥98%
|
|
| X23-10-ZQ371 |
JAK inhibitor Momelotinib, Purity ≥98%
|
|
| X23-10-ZQ372 |
JAK inhibitor CYT387 sulfate salt, Purity ≥98%
|
|
